0001593968-23-001520.txt : 20231220
0001593968-23-001520.hdr.sgml : 20231220
20231220162602
ACCESSION NUMBER: 0001593968-23-001520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231218
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MESSEMER DEBORAH M.
CENTRAL INDEX KEY: 0001754424
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 231501606
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
primary_01.xml
PRIMARY DOCUMENT
X0508
4
2023-12-18
0001737287
Allogene Therapeutics, Inc.
ALLO
0001754424
MESSEMER DEBORAH M.
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
Common Stock
2023-12-18
4
S
false
18640
2.6994
D
62456
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/Earl Douglas, Attorney-in-Fact
2023-12-20